Verastem Inc
NASDAQ:VSTM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Verastem Inc
NASDAQ:VSTM
|
US |
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
F
|
Fortinet Inc
SWB:FO8
|
US |
|
American Assets Trust Inc
NYSE:AAT
|
US |
|
Sterling Tools Ltd
NSE:STERTOOLS
|
IN |
|
P
|
Prosperity Investment Holdings Ltd
HKEX:310
|
HK |
|
Quilter PLC
LSE:QLT
|
UK |
|
H
|
Hecla Mining Co
LSE:0R0A
|
US |
|
S
|
Stelrad Group plc
LSE:SRAD
|
UK |
|
D
|
Dunelm Group PLC
OTC:DNLMY
|
UK |
|
Tamboran Resources Corp
OTC:TBNRL
|
AU |
|
Frontdoor Inc
NASDAQ:FTDR
|
US |
|
I
|
Itron Inc
DUS:IT6
|
US |
|
Parkmead Group PLC
LSE:PMG
|
UK |
|
Pieris Pharmaceuticals Inc
NASDAQ:PVLA
|
US |
Bankruptcy Probability
Verastem Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Verastem Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Verastem Inc
NASDAQ:VSTM
|
733.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Verastem Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Verastem Inc has total debt of 76.5m USD. This includes both short-term (214k USD) and long-term (76.3m USD) debt.
You can find a full breakdown on its Balance Sheet.